Re-examining HSPC1 inhibitors

HSPC1 is a critical protein in cancer development and progression, including colorectal cancer (CRC). However, clinical trial data reporting the effectiveness of HSPC1 inhibitors on several cancer types has not been as successful as predicted. Furthermore, some N-terminal inhibitors appear to be muc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sheah Lin, Dempsey-Hibbert, Nina Claire, Vimalachandran, Dale, Wardle, Terence David, Sutton, Paul A., Williams, John H. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352602/
https://www.ncbi.nlm.nih.gov/pubmed/28255900
http://dx.doi.org/10.1007/s12192-017-0774-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352602/
https://www.ncbi.nlm.nih.gov/pubmed/28255900
http://dx.doi.org/10.1007/s12192-017-0774-0

Ejemplares similares